Insights: Clinical cases

Test results can provide actionable answers for patients, even in the most unique and complex circumstances. This collection of clinical cases showcases how testing developed and supported by Mayo Clinic physicians and scientists can make a difference in the diagnosis and treatment of patients.

Neurology

When you choose Mayo Clinic Laboratories for your patients’ neurological testing needs, you get insights and guidance from a world-renowned medical center with more than 150 years of diagnostic experience. Offering the world’s most sophisticated test menu featuring multiple Mayo Clinic-developed assays that are unavailable elsewhere, we provide clients with cutting-edge evaluations to solve the most unique and complex cases.

Risk of false positives with AQP4 ELISA methodology

May 13, 2026

Learn more about the risks of false positives with AQP4 ELISA methodology in CNS demyelinating disease testing.

Treatable autoimmune encephalitis diagnosed with phenotype-specific evaluation

April 29, 2026

Learn how a phenotype-specific autoimmune neurology evaluation diagnosed a treatable autoimmune encephalitis condition that was missed with a traditional paraneoplastic evaluation.

Neurofascin 155 IgG4 antibodies, a specific marker of chronic inflammatory demyelinating polyradiculoneuropathy

April 22, 2026

Find out how our testing uses neurofascin 155 IgG4 antibodies as a specific marker of chronic inflammatory demyelinating polyradiculoneuropathy.

View More Return to first page

Rheumatology

Complex autoimmune and rheumatic diseases can present significant diagnostic challenges. Explore our featured clinical cases to discover how our advanced rheumatology testing and specialized expertise help clinicians diagnose and manage conditions such as lupus.

No posts available.